Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and myeloma-propagating pre-plasma cells in the bone marrow of multiple myeloma patients

समान संसाधन

• CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma
  द्वारा: Yousef, Sara, और अन्य
  प्रकाशित: (2015)
• Cancer-testis antigen MAGE-C2/CT10 induces spontaneous CD4(+) and CD8(+) T-cell responses in multiple myeloma patients
  द्वारा: Reinhard, H, और अन्य
  प्रकाशित: (2014)
• Immunotherapies targeting CD38 in Multiple Myeloma
  द्वारा: Atanackovic, Djordje, और अन्य
  प्रकाशित: (2016)
• CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide
  द्वारा: Radhakrishnan, Sabarinath V., और अन्य
  प्रकाशित: (2020)
• Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma
  द्वारा: Yousef, Sara, और अन्य
  प्रकाशित: (2015)